Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-004072
Filing Date
2025-03-31
Accepted
2025-03-31 07:07:37
Documents
171
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K irwd-20241231x10k.htm   iXBRL 10-K 3751466
2 EX-19.1 irwd-20241231xex19d1.htm EX-19.1 62117
3 EX-21.1 irwd-20241231xex21d1.htm EX-21.1 1564
4 EX-23.1 irwd-20241231xex23d1.htm EX-23.1 12303
5 EX-31.1 irwd-20241231xex31d1.htm EX-31.1 12950
6 EX-31.2 irwd-20241231xex31d2.htm EX-31.2 12904
7 EX-32.1 irwd-20241231xex32d1.htm EX-32.1 7382
8 EX-32.2 irwd-20241231xex32d2.htm EX-32.2 7328
9 GRAPHIC irwd-20241231x10k002.jpg GRAPHIC 40462
  Complete submission text file 0001558370-25-004072.txt   18461896

Data Files

Seq Description Document Type Size
10 EX-101.SCH irwd-20241231.xsd EX-101.SCH 138292
11 EX-101.CAL irwd-20241231_cal.xml EX-101.CAL 125007
12 EX-101.DEF irwd-20241231_def.xml EX-101.DEF 563792
13 EX-101.LAB irwd-20241231_lab.xml EX-101.LAB 1035594
14 EX-101.PRE irwd-20241231_pre.xml EX-101.PRE 997673
174 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20241231x10k_htm.xml XML 3427035
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34620 | Film No.: 25788821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)